Liver transplantation in tyrosinaemia type I: the Groningen experience.
作者： F. A. Wijburg , W. Ch. C. Reitsma , M. J. H. Slooff , F. J. van Spronsen , H. A. Koetse
DOI: 10.1007/BF00711743
关键词:
摘要: Dietary treatment cannot prevent a lethal outcome in many patients with hereditary tyrosinaemia type I (van Spronsen et al 1994). Therefore, until the discovery of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) as potential drug (Lindstedt 1992), orthotopic liver transplantation (OLT) was only definitive this disease 1989). We report our experiences OLT 9 I.
springer.com
sci-hub.se 参考文章(8)
FRANÇOIS I. LUKS, DICKENS STVIL, B. J. Hancock, JEAN-MARTIN LABERGE, ARIÉ L. BENSOUSSAN, PIERRE RUSSO, GRANT MITCHELL, MARIE LAMBERT, HERVÉ BLANCHARD, Surgical and metabolic aspects of liver transplantation for tyrosinemia. Transplantation. ,vol. 56, pp. 1376- 1380 ,(1993) , 10.1097/00007890-199312000-00019
AriéL. Bensoussan, Khazal Paradis, Pierre Brochu, Hervé Blanchard, Dickens St-Vil, François I. Luks, B.J. Hancock, Jean-Martin Laberge, Surgical aspects of liver transplantation for tyrosinemia Journal of Pediatric Surgery. ,vol. 28, pp. 578- 579 ,(1993) , 10.1016/0022-3468(93)90656-6
S LINDSTEDT, Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase The Lancet. ,vol. 340, pp. 813- 817 ,(1992) , 10.1016/0140-6736(92)92685-9
J. Jeffrey Malatack, J. Carlton Gartner, Andrew H. Urbach, Basil J. Zitelli, Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. The Journal of Pediatrics. ,vol. 118, pp. 667- 675 ,(1991) , 10.1016/S0022-3476(05)80024-1
A Salt, ND Barnes, K Rolles, RY Calne, PT Clayton, JV Leonard, Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation. Acta Paediatrica. ,vol. 81, pp. 449- 452 ,(1992) , 10.1111/J.1651-2227.1992.TB12270.X
Francjan J. Van Spronsen, Yolande Thomasse, G. Peter A. Smit, James V. Leonard, Peter T. Clayton, Vaclav Fidler, Ruud Berger, Hugo S. A. Heymans, Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment Hepatology. ,vol. 20, pp. 1187- 1191 ,(1994) , 10.1002/HEP.1840200513
F. J. van Spronsen, R. Berger, G. P. A. Smit, J. B. C. de Klerk, M. Duran, C. M. A. Bijleveld, H. van Faassen, M. J. H. Slooff, H. S. A. Heymans, Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem. Journal of Inherited Metabolic Disease. ,vol. 12, pp. 339- 342 ,(1989) , 10.1007/BF03335416
David H. Van Thiel, Lawrence M. Gartner, Frank K. Thorp, Stephen L. Newman, Julie A. Lindahl, Elizabeth Stoner, Maria I. New, Thomas E. Starzl, Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma Journal of Hepatology. ,vol. 3, pp. 42- 48 ,(1986) , 10.1016/S0168-8278(86)80144-1